Abstract
Non-scaling Fixed Field Alternating Gradient accelerators (ns-FFAGs) show great potential for the acceleration of protons and light ions for the treatment of certain cancers. They have unique features as they combine techniques from the existing types of accelerators, cyclotrons and synchrotrons, and hence look to have advantages over both for this application. However, these unique features meant that it was necessary to build one of these accelerators to show that it works and to undertake a detailed conceptual design of a medical machine. Both of these have now been done. This paper will describe the concepts of this type of accelerator, show results from the proof-of-principle machine (EMMA) and described the medical machine (PAMELA).
| Original language | English |
|---|---|
| Title of host publication | Application of Accelerators in Research and Industry |
| Subtitle of host publication | Twenty-Second International Conference |
| Editors | Floyd D. McDaniel, Barney L. Doyle, Gary A. Glass, Yongqiang Wang |
| Publisher | AIP Publishing LLC |
| Pages | 323-326 |
| Number of pages | 4 |
| Volume | 1525 |
| Edition | 1 |
| ISBN (Print) | 9780735411487 |
| DOIs | |
| Publication status | Published - 19 Apr 2013 |
| Event | 22nd International Conference on the Application of Accelerators in Research and Industry - Fort Worth, United States Duration: 5 Aug 2012 → 10 Aug 2012 Conference number: 22 |
Publication series
| Name | AIP Conference Proceedings |
|---|---|
| Volume | 1525 |
| ISSN (Print) | 0094-243X |
| ISSN (Electronic) | 1551-7616 |
Conference
| Conference | 22nd International Conference on the Application of Accelerators in Research and Industry |
|---|---|
| Abbreviated title | CAARI 2012 |
| Country/Territory | United States |
| City | Fort Worth |
| Period | 5/08/12 → 10/08/12 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'A new type of accelerator for charged particle cancer therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver